ApoRx is a drug discovery company focusing on the discovery, design, characterization, and development of small proteolysis targeting molecules (PTMs) against well-validated disease-causing proteins in cancer and other indications.
Our technology is based on a proprietary focus library of RING E3 ligase binders and is designed to harness the intracellular Ubiquitin-Proteasome machinery to degrade and destroy unwanted proteins by Targeted Protein Degradation.
Company Details
- Employees
- 4
- Founded
- 2021
- Address
- Nes Tziona, Il
- Industry
- Biotechnology
- Website
- http://www.aporxbio.com
- Keywords
- Protein degradation, PROTAC, Molecular glue, Ligases, E3, RING, Proteasome, Ubiquitin, Proteasomal degradation, Drug discovery, Drug design, Degraders.
- HQ
- Nes Tziona
Aporx Questions
Aporx's website is http://www.aporxbio.com
Aporx's LinkedIn profile is https://il.linkedin.com/company/aporx
Aporx has
4 employees.
View email and phone details for 4
employees at Aporx.
Aporx's industry is
Biotechnology
Aporx's top competitors are
Celleste Bio,
Benevia Coffee,
Tripod Therapeutics,
Whitewater Ventures Llc,
Agbiopro,
Sea2cell,
Biokine.com.mx,
Cannamore Biotechs,
Stero Biotechs,
Pi Therapeutics.
Aporx's categories are Biotechnology
Aporx's founding year is 2021
